Esma Saâda

69 papers receiving 924 citations

Esma Saâda's Hit Papers

NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse. 2025 · 18 citations
180+2+5Years since publication50100150200

Peers

Esma Saâda
Comparison fields: 5 of 64
  • Otorhinolaryngology 153
  • Pulmonary and Respiratory Medicine 409
  • Oncology 311
  • Rheumatology 90
  • Gastroenterology 25
Replace Marián Švajdler with:
Marián Švajdler Czechia
Siddhartha Laskar India
Javier Aristu Spain
Milan Vošmik Czechia
Douglas Adkins United States
Y.A. Abuodeh United States
Nils Mandahl Sweden
Alexander Rehders Germany
L. Geoffrois France
Tamara Rordorf Switzerland
Esma Saâda relative to Marián Švajdler Czechia Marián Švajdler's profile →
Citations per field
00.5×3.9×
Marián Švajdler · 1×
Citations per year

Countries citing papers authored by Esma Saâda

Since Specialization
Citations

This map shows the geographic impact of Esma Saâda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esma Saâda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esma Saâda more than expected).

Fields of papers citing papers by Esma Saâda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esma Saâda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esma Saâda. The network helps show where Esma Saâda may publish in the future.

Co-authors

The 25 scholars most cited alongside Esma Saâda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Esma Saâda Line = papers co-authored together Esma Saâda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study
Hit paper breakdown →
2018240
2 201467
3 202062
4 202132
5 202026
6 202025
7 200924
8 201521
9 201320
10 201920
11 201119
12
NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.
Hit paper breakdown →
202518
13 201918
14 201417
15 201817
16 201616
17 201915
18 201614
19 201614
20 201413

About Esma Saâda

Esma Saâda is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Otorhinolaryngology, Pathology and Forensic Medicine and Surgery, having authored 70 papers that have together received 934 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (22 papers), Sarcoma Diagnosis and Treatment (20 papers), Cancer Immunotherapy and Biomarkers (9 papers), Lymphoma Diagnosis and Treatment (5 papers), Cardiac tumors and thrombi (4 papers), Cancer Diagnosis and Treatment (4 papers), Gastrointestinal Tumor Research and Treatment (4 papers) and Head and Neck Surgical Oncology (4 papers). The work is most often cited by research in Otorhinolaryngology (153 citations), Pulmonary and Respiratory Medicine (409 citations), Oncology (311 citations), Rheumatology (90 citations) and Gastroenterology (25 citations). Esma Saâda has collaborated with scholars based in France, Spain and United States. Frequent co-authors include Antoîne Italiano, Nicolás Isambert, Nicolas Penel, Jean‐Yves Blay, Sophie Piperno‐Neumann, Christine Chevreau, Elsa Kalbacher, Emmanuelle Bompas, Olivier Mir and Olivier Collard. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Archives of Oto-Rhino-Laryngology, European Journal of Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact